Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | GLS | O94925 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11082919 | 0.92 | ALDH1A1 (0.47) | TSHRALDH1A1HSD17B10PLA2G4BKMT2A | |
| SCHEMBL26777323 | 0.89 | TSHR (0.50) | TSHRALDH1A1PLA2G4BKMT2ALMNA | |
| SCHEMBL112204 | 0.85 | TSHR (0.63) | TSHRALDH1A1HSD17B10KMT2AMEN1 | |
| SCHEMBL15282755 | 0.83 | TSHR (0.60) | TSHRALDH1A1HSD17B10KMT2AMEN1 | |
| SCHEMBL15631195 | 0.82 | TSHR (0.50) | TSHRALDH1A1HSD17B10PLA2G4BKMT2A | |
| SCHEMBL12421758 | 0.82 | ALDH1A1 (0.42) | TSHRALDH1A1HSD17B10PLA2G4BKMT2A | |
| SCHEMBL12417193 | 0.81 | LMNA (0.50) | TSHRALDH1A1PLA2G4BKMT2AMEN1 | |
| SCHEMBL14353413 | 0.81 | TSHR (0.67) | TSHRALDH1A1HSD17B10KMT2AMEN1 | |
| SCHEMBL23135308 | 0.80 | ALDH1A1 (0.41) | TSHRALDH1A1HSD17B10PLA2G4BKMT2A | |
| SCHEMBL11345104 | 0.80 | TSHR (0.48) | TSHRALDH1A1HSD17B10KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304565-B2 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2012-11-06 | — | — | US | disclosed |
| US-8304565-B2 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2012-11-06 | — | — | US | disclosed |
| US-20100210518-A1 | Peg-lipid conjugates for increasing the solubility of drug compounds | KELLER BRIAN CHARLES | 2010-08-19 | — | — | US | disclosed |
| US-20100210518-A1 | Peg-lipid conjugates for increasing the solubility of drug compounds | KELLER BRIAN CHARLES | 2010-08-19 | — | — | US | disclosed |
| US-20100143455-A1 | Triazole antifungal agents | WU NIAN | 2010-06-10 | — | — | US | disclosed |
| US-20100143455-A1 | Triazole antifungal agents | WU NIAN | 2010-06-10 | — | — | US | disclosed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | disclosed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | disclosed |
| WO-2010027496-A1 | TRIAZOLE ANTIFUNGAL AGENTS | WU NIAN (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | DAGLA, DAGLB, DGKG | TSHR 2520/4885ALDH1A1 2787/4885HSD17B10 862/4885 |
| US-20100210518-A1 | Peg-lipid conjugates for increasing the solubility of drug compounds | LIPA, DAGLA, MGLL | TSHR 3980/4885ALDH1A1 1595/4885HSD17B10 397/4885 |
| US-20100143455-A1 | Triazole antifungal agents | CYP3A7, ERG28, UGT1A7 | TSHR 2904/4885ALDH1A1 3869/4885HSD17B10 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.